DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Simcere Pharmaceutical
Simcere Pharmaceutical
Pharma China0409-285.P65
China Pharmaceutical Newsletter
Download Table of Contents [PDF 1
Pharmaceutical Innovation in the APAC Region
Simcere Pharmaceutical Group Limited 先聲藥業集團有限公司 (The “Company”) (A Company Incorporated in Hong Kong with Limited Liability)
Pharma China-201012.P65
China Regulatory and Market Access Pharmaceutical Report 2014
SIMCERE PHARMA GROUP [E/O] CRC: 41999 BOMH02229 001.00.00.00 0/4 H02229.SUB, Docname: 20-F, Doc: 1, Page: 1 *H02229/001/4* Description: FORM 20-F EDGAR 2
Tender Watcher – Drugs: Guangdong Tender Rules Changed Again (For
New Landscape of Pharmaceutical Manufacturing in China.Pdf
NOVATION Contents INDUSTRIALIZATION INDUSTRIALIZATION
Simcere Pharmaceutical Group (2096 HK) BUY (Initiation)
2020 Interim Results Presentation
Meeting Incoming Jiangsu Pharmaceutical R&D Delegation REGISTRATION
The Chinese Pharmaceutical Market to 2024 Commercial & Strategic Developments in the Chinese Pharmaceutical Market to 2024
Simcere Pharmaceutical Group Limited 先聲藥業集團有限公司
Listing of Global Companies with Ongoing Government Activity
2020 Annual Report 年度報告 Contents
Top View
Biocentury: Powering Down Cancer
Healthcare & Life Sciences in China – Towards Growing Collaboration
The Next Phase: Opportunities in China's Pharmaceuticals Market